Latest Fund Strategy News

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Mayfield Childcare Limited’s board has issued a Target’s Statement recommending shareholders reject Embark Early Education’s unsolicited takeover offer, citing undervaluation and significant risks. The offer, which includes a scrip or cash option, is seen as opportunistically timed amid Mayfield’s operational turnaround.

Auking Mining Limited reported a cash burn in its latest quarterly report but is moving ahead with a $1.5 million capital raising to fund key exploration projects.

Hiremii Group has raised $1.764 million through a strategic placement to fuel growth of its AI-driven recruitment platform and appointed Vaughan Webber as its new Chair.

L1 Group Limited reported a $700 million increase in assets under management for the December quarter, driven by strong inflows and positive returns, while performance fees are expected to reach nearly $39 million.

Ryzon Materials Limited faces ASX scrutiny over the timing and disclosure of a $1 million advance from Xinhai Mining, with the company responding to regulatory queries and committing to improved governance.

Montaka Global Fund – Active ETF (ASX – MOGL) has announced a distribution of 10.80 cents per unit for the quarter ending 31 December 2025, alongside details of its Distribution Reinvestment Plan and tax status.

Meteoric Resources has received a conditional Letter of Support from Export Finance Australia for up to US$50 million to advance its Caldeira Rare Earth Project in Brazil, complementing prior US financing interest and reinforcing Australia-Brazil supply chain ties.

Taiton Resources has completed the first tranche of its capital raising, issuing 3.38 million shares to sophisticated investors, with a larger tranche still pending. This move aims to bolster funding for its mineral exploration projects across South Australia and New South Wales.

Globe Metals & Mining has issued over 56 million shares to Director Bo Tan, settling nearly all of an outstanding loan and achieving a fully debt-free status. This financial milestone positions the company strongly for advancing its Kanyika Niobium Project.

Caravel Minerals reports substantial progress on its Definitive Feasibility Study for the Caravel Copper Project, advancing engineering, environmental approvals, and strategic partnerships toward development.

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.